Furthermore, most immune checkpoint genes, including PD-1, PD-L1, PDCD1LG2, CTLA4, HAVCR2, LAG3, TIGHT and SIGLEC15, were highly expressed in the hepcidin high-expression group of patients with LGG and GBM (Figure 8F). This evidence concerns the gene HAVCR2 and glioblastoma.